Five minutes with: Professor Patti Gravitt
Our “Five Minutes With” series seeks to discover what are the habits, inspirations and obstacles that have shaped the careers of leading cancer researchers and […]
HPV
Global Perspectives on Screening: Sub-Saharan Africa
Changing burdens of disease When we discuss the burden of disease in regions such as Sub-Saharan Africa (SSA), our mind immediately jumps to examples such […]
10 must read papers from the last year
We are celebrating our first-year anniversary! We hope you have enjoyed our blog thus far. To celebrate we thought we would highlight ten (18 but […]
Cervical Cancer: The Epidemic that never was!
Trying to say what would have happened is difficult. Alternate history is a type of fiction that explores what might have happened if a particular […]
From theory to practice: HPV testing in cervical screening really does work!
After months of eager anticipation, the results from the English HPV implementation pilot have been published. Compared to current screening HPV testing detected 50% more […]
Does the quality and type of screening test matter when determining safe intervals between cervical screening tests?
The question of “how often should women go for cervical screening?” has long been controversial. In the past, many countries recommended screening annually whereas in […]
Cervical Screening Programme change in Wales: what has Cervical Screening Wales done about it?
Guest blog post by: Dr Simon Leeson (NHS Wales) On Monday 17th September, Wales will become the first nation in the UK to fully convert its cervical […]
Further evidence of the success of the National HPV Immunisation programme in England
Guest blog post by: David Mesher, Public Health England The National HPV Immunisation Programme The National HPV Immunisation Programme was introduced in England in 2008, […]
Rates of cervical cancer in women aged 20-24 in England seen to double – should we be worried?
The HPV virus causes most cases of cervical cancer. This is why an HPV vaccination programme for girls aged 12 to 13 started in 2008. […]
Is it safe to export cancer screening?
A woman in the Republic of Ireland, Vicky Phelan, recently settled with a laboratory in America receiving $2.5million compensation for them missing abnormalities on her […]